11/08/2024 4:00 PM | Khattar Jack A. (Reporting) Supernus Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2024 3:19 PM | GEMAYEL GEORGES (Reporting) Supernus Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2024 3:08 PM | Khattar Jack A. (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/08/2024 3:11 PM | GEMAYEL GEORGES (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/07/2024 3:59 PM | Khattar Jack A. (Reporting) Supernus Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2024 3:42 PM | GEMAYEL GEORGES (Reporting) Supernus Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/04/2024 3:19 PM | Supernus Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
|
11/01/2024 3:35 PM | MACQUARIE GROUP LTD (Filed by) Supernus Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/31/2024 10:55 AM | DIMENSIONAL FUND ADVISORS LP (Filed by) Supernus Pharmaceuticals (Subject)
| Form SC 13G | |
10/21/2024 3:48 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/17/2024 3:16 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/10/2024 4:03 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/13/2024 3:30 PM | GEMAYEL GEORGES (Reporting) Supernus Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024 4:00 PM | Bhatt Padmanabh P. (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/19/2024 6:03 AM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/06/2024 3:16 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/06/2024 3:18 PM | Supernus Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024 3:19 PM | Martin Tami Tillotson (Reporting) Supernus Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/31/2024 3:41 PM | Martin Tami Tillotson (Reporting) Supernus Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/24/2024 3:48 PM | Martin Tami Tillotson (Reporting) Supernus Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/23/2024 3:20 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/22/2024 3:24 PM | Martin Tami Tillotson (Reporting) Supernus Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/19/2024 3:28 PM | Martin Tami Tillotson (Reporting) Supernus Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024 3:14 PM | Martin Tami Tillotson (Reporting) Supernus Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024 3:18 PM | Martin Tami Tillotson (Reporting) Supernus Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024 3:53 PM | Martin Tami Tillotson (Reporting) Supernus Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024 4:15 PM | Supernus Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/09/2024 3:09 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/24/2024 3:05 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/24/2024 3:08 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/08/2024 7:03 AM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/25/2024 4:00 PM | Bhatt Padmanabh P. (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 4:00 PM | Bhatt Padmanabh P. (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/21/2024 4:01 PM | Bhatt Padmanabh P. (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 5:39 PM | Bhatt Padmanabh P. (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/14/2024 4:00 PM | Bhatt Padmanabh P. (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 3:23 PM | Bhatt Padmanabh P. (Reporting) Supernus Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024 4:00 PM | Khattar Jack A. (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 4:01 PM | Mottola Frank (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/22/2024 4:28 PM | Khattar Jack A. (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 1:33 PM | ARMISTICE CAPITAL, LLC (Filed by) Supernus Pharmaceuticals (Subject)
| Form SC 13G/A | |
JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad) Trump's back in the White House, but Wall Street is pissed.
Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback. Get your free guide NOW before it's too late. |
02/14/2024 6:06 AM | MACQUARIE GROUP LTD (Filed by) Supernus Pharmaceuticals (Subject)
| Form SC 13G | |
02/05/2024 8:21 AM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/19/2024 1:40 PM | BlackRock Inc. (Filed by) Supernus Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/10/2024 3:08 PM | Martin Tami Tillotson (Reporting) Supernus Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/26/2023 4:00 PM | Khattar Jack A. (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/26/2023 4:01 PM | Rubin Jonathan (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |